About Taiho Pharmaceuticals
Taiho Pharmaceuticals is a Healthcare company based in Chiyoda (Japan) founded in 1963. A Japanese biopharmaceutical company specializing in oncology. It operates on a B2B model. Taiho Pharmaceuticals has completed 2 acquisitions, including Araris Biotech and Cullinan Pearl. Its focus areas include Pharmaceuticals, Biopharmaceuticals and Oncology.
Company details
Taiho Pharmaceuticals a japanese biopharmaceutical company specializing in oncology, focusing on providing healthcare solutions, producing pharmaceutical products, biopharmaceuticals, and oncology. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Chiyoda, Japan
- SectorsHealthcare
- Website taiho.co.jp
- Social Facebook
- Investments & AcquisitionsAraris Biotech
& 1 more
People of Taiho Pharmaceuticals
5 people are tracked at Taiho Pharmaceuticals (3 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Yasuhiro Imaeda | Director, Technology-enabled Drug Discovery / 創薬基盤技術研究所 所長 | Leadership |
Kazuyoshi Shiraishi | President and Representative Director | Leadership |
Pieter Kooiman | Senior Director Finance | Leadership |
Kentaro Ogawa | Global Human Resources Manager | Team |
Hitoshi Ono | Business Development | Team |
Complete people profiles for Taiho Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Taiho Pharmaceuticals
Taiho Pharmaceuticals has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Araris Biotech and Cullinan Pearl.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Proprietary peptide linker technology for antibody-drug conjugates is developed. | ararisbiotech.com | Zurich, Switzerland | 2019 | Mar 2025 | $1.1B | |
Therapeutics for cancer treatment are developed by Cullinan Pearl. | cullinanpearl.tcc.mode | 0 | May 2022 | •••• |
Complete acquisition details for Taiho Pharmaceuticals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Taiho Pharmaceuticals
3 dated milestones of Taiho Pharmaceuticals across 62 years, from founding to its latest funding, stage changes and deals.
- Founded Taiho Pharmaceuticals is founded.
- Acquisition Acquires Cullinan Pearl.
- Acquisition Acquires Araris Biotech.
Web traffic of Taiho Pharmaceuticals
Websites that share an audience with Taiho Pharmaceuticals (taiho.co.jp).
Websites whose visitors overlap most with Taiho Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pharmamar.com | 100% | 13.4K | View details | ||
| wakamoto-pharm.co.jp | 93% | 203.2K | #227,483 | View details | |
| chemiphar.co.jp | 86% | 11.3K | #1,681,821 | View details | |
| rohto.co.jp | 86% | 1.2M | #61,757 | View details | |
| kaken.co.jp | 82% | 39.1K | #763,861 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Taiho Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Taiho Pharmaceuticals
Complete news archive for Taiho Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Taiho Pharmaceuticals
Taiho Pharmaceuticals was founded in 1963.
Taiho Pharmaceuticals is headquartered in Chiyoda, Japan. It is registered at Chiyoda, Tokyo, Japan.
Taiho Pharmaceuticals a japanese biopharmaceutical company specializing in oncology, focusing on providing healthcare solutions, producing pharmaceutical products, biopharmaceuticals, and oncology. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Taiho Pharmaceuticals has made 2 acquisitions, including Araris Biotech, and Cullinan Pearl.